Sign in to continue:

Saturday, April 4th, 2026
Stock Profile: DAWN
DAWN Logo

Day One Biopharmaceuticals, Inc. (DAWN)

Market: NMS | Currency: USD

Address: 2000 Sierra Point Parkway

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.



📈 Day One Biopharmaceuticals, Inc. Historical Chart





📊 Statistics




💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for Day One Biopharmaceuticals, Inc.


DateReported EPS
2026-05-05 (estimated upcoming)-
2026-02-24-0.21
2025-11-04-0.19
2025-08-05-0.29
2025-05-06-0.35
2025-02-25-0.63
2024-10-300.38
2024-07-30-0.05
2024-05-06-0.72
2024-02-26-0.64
2023-11-06-0.54
2023-08-07-0.61
2023-05-01-0.59
2023-03-06-0.56
2022-11-07-0.53
2022-08-04-0.6
2022-05-12-0.48
2022-03-07-0.35
2021-11-08-0.33
2021-08-10-5.04



📰 Related News & Research


🔍 View more Reports